Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Cytares Injection

Prescription Icon
Prescription Required

Marketer

Resonance Laboratories Pvt Ltd

Salt Composition

Cytarabine (100mg/ml)

Overview Cytares Injection

Oncocyte Injection is indicated for the management of specific hematological malignancies. Its use may extend to other conditions under physician supervision, potentially as part of a combined chemotherapy regimen. Administered intravenously or subcutaneously by a healthcare professional, the dosage and frequency are individualized by the treating physician based on the patient's condition and may be adjusted. Strict adherence to the prescribed regimen is crucial, as incorrect usage or overdose can lead to severe adverse reactions. While therapeutic effects might not be immediately apparent, discontinuation should only occur under medical guidance. Commonly reported adverse events include dermatological reactions (rash, skin lesions), gastrointestinal upset (nausea, vomiting), and alopecia. The medication can suppress blood cell production, increasing infection and bleeding risks. Report any signs of infection (chills), abnormal bleeding or bruising, or melena (dark, tarry stools) immediately. Regular blood work monitoring, encompassing blood cell counts, hepatic and renal function, and uric acid levels, is essential. Prior to commencing treatment, disclose any pre-existing bleeding disorders, hepatic or renal impairment, or concurrent use of anti-infective agents. Numerous drug interactions are possible; therefore, a comprehensive medication history should be provided. This medication is contraindicated during pregnancy and lactation. Effective contraception is strongly advised for both partners throughout the treatment period.

Uses of Cytares Injection

Hematologic malignancy

Major Benefits of Cytares Injection:

This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.

Common Side effects of Cytares Injection:

  • Rash
  • Skin ulcer
  • Nausea
  • Vomiting
  • Hair loss
  • Abdominal pain
  • Anal ulcers
  • Anemia (low number of red blood cells)
  • Decreased white blood cell count
  • Fever
  • Infection
  • Abnormal liver function
  • Low blood platelets
  • Mouth ulcer
  • Pneumonia
  • Sepsis
  • Mouth sore
  • Stomatitis (Inflammation of the mouth)

How to use Cytares Injection:

This medication will be administered by your healthcare provider; please do not attempt self-medication.

How Cytares Injection works:

Cytares Injection disrupts cancer cell proliferation by replacing essential DNA and RNA components, thereby halting their growth and replication.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Cytares Injection presents unknown safety implications. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Cytares Injection during pregnancy is contraindicated due to established fetal risks. In exceptional, life-threatening circumstances, a physician might deem its use acceptable if the potential benefits outweigh the known hazards. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Administration of Cytares Injection is contraindicated while breastfeeding due to potential infant toxicity indicated by available data.

DrivingDrivingUNSAFE

Driving ability may be impaired by side effects associated with Cytares Injection.

KidneyKidneySAFE IF PRESCRIBED

Cytares Injection poses no safety concerns for patients with kidney impairment; dosage modification is unnecessary. Nevertheless, consult your physician regarding any pre-existing kidney conditions.

LiverLiverCONSULT YOUR DOCTOR

Data on Cytares Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised. Given this limited data, a conservative approach to Cytares Injection administration is recommended for patients with liver disease.

What if you forget to take Cytares Injection :

NA

Facts to Know About Cytares Injection

LabelValue
Chemical Type Pyrimidine Nucleoside Analogue
Developing Habits No.
Type of Therapy Cancer Drugs
Actions Metabolic antagonists

FAQs on Cytares Injection

Cytares Injection is non-vesicant, but careful handling is required.
Cytares Injection is not known to cause ototoxicity. However, report any hearing problems to your doctor.
Cytares Injection is indeed cytotoxic.
Hair loss is a possible side effect of Cytares Injection.
Cytares Injection blocks DNA replication by inhibiting DNA synthesis.
Cytares Injection
460
MRP 560
17% off